Full Professor of Surgery at the Medical University of Vienna, Austria, where he also serves as President of the Austrian Breast and Colorectal Cancer Study Group. He has been co-chairing and hosting St. Gallen International Consensus Panel for Early Breast Cancer since 2015 and is involved in many scientific societies including ASCO, AACR, ACS, BIG, EORTC, ESSO, EUSOMA, and UICC.​

Prof. Michael Gnant has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Amgen, AstraZeneca, Bayer, Daiichi Sankyo, Eli Lilly, EPG Health (IQVIA), Menarini Stemline, MSD, Novartis, Pierre Fabre, and Veracyte​